The National Institute for Health and Care Excellence

'I could go to work again': prescriptions for NICE-recommended endometriosis and fibroid tablets soar

NICE recommends the tablets for adults with moderate to severe fibroid symptoms. Linzagolix is recommended for longer-term treatment, with the dose depending on the patient. For endometriosis, they ...
The National Institute for Health and Care Excellence

New AI tools could help spot prostate cancer more accurately

Innovative AI technologies have the potential to act like a ‘second pair of eyes’, helping radiologists review prostate MRI scans.
The National Institute for Health and Care Excellence

Faster dementia diagnosis: inside UKRI's £80 million Dementia Challenge

From blood-based biomarkers to AI-powered tools, discover how 9 innovations are being tested in the NHS to speed up dementia ...
National Institute for Health and Care Excellence

Published guidance, NICE advice and quality standards

Digital technologies for managing non-specific low back pain: early value assessment HTG712 5 March 2024 23 October 2026 Digitally enabled therapies for adults with anxiety disorders: early value ...
National Institute for Health and Care Excellence

Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (terminated appraisal)

Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (terminated appraisal) Technology appraisal guidance TA987 Published: 10 July 2024 Register as a ...
National Institute for Health and Care Excellence

OpenAthens eligibility

Note: Healthcare students at universities which have an OpenAthens administrator can have an NHS OpenAthens account for the duration of their course. Students at these universities will have NHS ...
National Institute for Health and Care Excellence

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It ...
National Institute for Health and Care Excellence

Patients to get new medicines 3 to 6 months faster

An aligned pathway between the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE, along with an improved advice service, will help bring medicines to patients faster and give ...
National Institute for Health and Care Excellence

Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease

Evidence-based recommendations on nivolumab (Opdivo) for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease in adults. This guidance updates and ...
National Institute for Health and Care Excellence

Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency

Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency Technology appraisal guidance ...
National Institute for Health and Care Excellence

Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer

Evidence-based recommendations on amivantamab (Rybrevant) with carboplatin and pemetrexed for untreated advanced non-small-cell lung cancer with activating EGFR exon 20 insertion mutations in adults.
National Institute for Health and Care Excellence

Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer

Guidance Standards and indicators Clinical Knowledge Summaries (CKS) British National Formulary (BNF) BNF for Children (BNFC) Life sciences Library and knowledge services What NICE does Implementing ...